156 related articles for article (PubMed ID: 32237268)
1. Activated platelets kill Staphylococcus aureus, but not Streptococcus pneumoniae-The role of FcγRIIa and platelet factor 4/heparinantibodies.
Wolff M; Handtke S; Palankar R; Wesche J; Kohler TP; Kohler C; Gruel Y; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2020 Jun; 18(6):1459-1468. PubMed ID: 32237268
[TBL] [Abstract][Full Text] [Related]
2. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.
Palankar R; Kohler TP; Krauel K; Wesche J; Hammerschmidt S; Greinacher A
J Thromb Haemost; 2018 Jun; 16(6):1187-1197. PubMed ID: 29350833
[TBL] [Abstract][Full Text] [Related]
3. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia.
Krauel K; Pötschke C; Weber C; Kessler W; Fürll B; Ittermann T; Maier S; Hammerschmidt S; Bröker BM; Greinacher A
Blood; 2011 Jan; 117(4):1370-8. PubMed ID: 20959601
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death.
Nevzorova TA; Mordakhanova ER; Daminova AG; Ponomareva AA; Andrianova IA; Le Minh G; Rauova L; Litvinov RI; Weisel JW
Cell Death Discov; 2019; 5():106. PubMed ID: 31263574
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
[TBL] [Abstract][Full Text] [Related]
8. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
[TBL] [Abstract][Full Text] [Related]
9. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
[TBL] [Abstract][Full Text] [Related]
10. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4.
Arman M; Krauel K; Tilley DO; Weber C; Cox D; Greinacher A; Kerrigan SW; Watson SP
Blood; 2014 May; 123(20):3166-74. PubMed ID: 24642751
[TBL] [Abstract][Full Text] [Related]
11. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
12. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation.
Newman PM; Chong BH
Blood; 2000 Jul; 96(1):182-7. PubMed ID: 10891449
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of platelet-activating and nonplatelet-activating anti-PF4/heparin antibodies in enzyme immunosorbent assays under different conditions.
Nguyen TH; Wesche J; Raschke R; Strobel U; Bui VC; Delcea M; Greinacher A
J Thromb Haemost; 2019 Jul; 17(7):1113-1119. PubMed ID: 31009154
[TBL] [Abstract][Full Text] [Related]
15. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity.
Nguyen TH; Medvedev N; Delcea M; Greinacher A
Nat Commun; 2017 May; 8():14945. PubMed ID: 28530237
[TBL] [Abstract][Full Text] [Related]
16. Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?
Sarkar A; Khandelwal S; Koma GT; Kim H; Gruel Y; Rollin J; Passam F; Wool GD; Arepally GM; Cines DB; Rauova L; Poncz M
Blood Adv; 2023 Aug; 7(15):4112-4123. PubMed ID: 37196641
[TBL] [Abstract][Full Text] [Related]
17. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology.
Pouplard C; Rollin J; Vayne C; Charuel N; Ahmadi Z; Alberio L; Azjenberg N; Althaus K; Bakchoul T; Chong B; Curtis BR; Faille D; Gomez FJ; Gresele P; Morel-Kopp MC; Mullier F; Nazy I; Smith JW; Greinacher A; Gruel Y
J Thromb Haemost; 2022 Jan; 20(1):252-259. PubMed ID: 34657390
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
[TBL] [Abstract][Full Text] [Related]
19. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes.
Krauel K; Weber C; Brandt S; Zähringer U; Mamat U; Greinacher A; Hammerschmidt S
Blood; 2012 Oct; 120(16):3345-52. PubMed ID: 22942185
[TBL] [Abstract][Full Text] [Related]
20. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]